Support Us — Your donation helps us keep running

Goal: 1000 CNY,Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-3264
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Broken or Risky Cryptographic Algorithm in Mia Technology's Mia-Med Health Aplication
Source: NVD (National Vulnerability Database)
Vulnerability Description
Use of a Broken or Risky Cryptographic Algorithm vulnerability in Mia Technology Inc. Mia-Med Health Aplication allows Signature Spoofing by Improper Validation.This issue affects Mia-Med Health Aplication: before 1.0.14.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
使用已被攻破或存在风险的密码学算法
Source: NVD (National Vulnerability Database)
Vulnerability Title
Mia Technology MIA-MED 加密问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Mia Technology MIA-MED是Mia Technology公司的一个医院管理系统。 Mia Technology MIA-MED 1.0.14之前版本存在加密问题漏洞,该漏洞源于存在损坏或危险的加密算法,从而通过不当验证进行签名欺骗。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
Mia Technology Inc.Mia-Med Health Aplication 0 ~ 1.0.14 -
II. Public POCs for CVE-2024-3264
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-3264
Please Login to view more intelligence information
New Vulnerabilities
V. Comments for CVE-2024-3264

No comments yet


Leave a comment